West Pharmaceutical Services Inc

Common Name
West Pharmaceutical Services
Country
United States
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
10,600
Ticker
WST
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
West Pharmaceutical Services, Inc. is a leading provider of innovative solutions for injectable drug administration, operating in the life sciences tools and services industry. Established in 1923, th...

West Pharmaceutical Services's GHG Emissions Data Preview

In 2024, West Pharmaceutical Services completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, West Pharmaceutical Services has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Data

Verified Sources Behind West Pharmaceutical Services’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore West Pharmaceutical Services’s data sources below and access millions more through our Disclosure Search.

a. West Pharmaceutical Services's Sustainability Report 2024
a. West Pharmaceutical Services's Sustainability Report 2024
b. West Pharmaceutical Services's ESG Report 2023
b. West Pharmaceutical Services's ESG Report 2023
c. West Pharmaceutical Services's Sustainability Report 2019
c. West Pharmaceutical Services's Sustainability Report 2019

Insights into West Pharmaceutical Services's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of West Pharmaceutical Services amounted to 97,903 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of West Pharmaceutical Services decreased by 6.03%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

West Pharmaceutical Services's Scope 1 Emissions Over Time

201820192020202120222023202408 k16 k24 k32 ktCO2e-6%+5%+6%0%-1%+1%
  • Total Scope 1
  • Year-over-Year Change

What are West Pharmaceutical Services's Scope 1 emissions?

In 2024, the total Scope 1 emissions of West Pharmaceutical Services were 31,327 metric tons of CO₂ equivalent (tCO₂e). a

Has West Pharmaceutical Services reduced its Scope 1 emissions over time?

Since 2018, West Pharmaceutical Services's Scope 1 emissions have increased by 4.26%, reflecting a rising long-term trend in Scope 1 emissions over time. a c

Compared to the previous year (2023), West Pharmaceutical Services's Scope 1 emissions remained relatively stable, indicating that West Pharmaceutical Services's emissions have plateaued with no significant change in its operational footprint. a

What are West Pharmaceutical Services's Scope 2 emissions?

In 2024, West Pharmaceutical Services reported Scope 2 greenhouse gas (GHG) emissions of 66,576 tCO₂e without specifying the calculation method. a

Has West Pharmaceutical Services reduced its Scope 2 emissions over time?

Since 2018, West Pharmaceutical Services's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 39.09%, reflecting a declining long-term trend in Scope 2 emissions over time. a c

Compared to the previous year (2023), West Pharmaceutical Services's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that West Pharmaceutical Services 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does West Pharmaceutical Services use for Scope 2 reporting?

In 2024, West Pharmaceutical Services reported its Scope 2 emissions using an unspecified methodology. a

West Pharmaceutical Services's Scope 2 Emissions Over Time

2018201920202021202220232024030 k60 k90 k120 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into West Pharmaceutical Services’s GHG Emissions Intensity Compared to Industry Peers

In 2024, West Pharmaceutical Services reported Scope 1 greenhouse gas (GHG) emissions of 31,327 tCO₂e and total revenues of USD 2,893 millions. This translates into an emissions intensity of 10.83 tCO₂e per millions USD. a

West Pharmaceutical Services's Scope 1 Emissions Intensity Compared to Peers

2002,00020,000100,0001,000,000Scope 1 Emissions (tCO2e)2005002,00010,00050,000Revenues (Millions of USD)Bio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$MAzentaYear: 2023Scope 1: 14,399 tCO2eRevenue: $M 665Scope 1 Intensity: 21.65 tCO2e/$MResmedYear: 2023Scope 1: 4,453 tCO2eRevenue: $M 4,223Scope 1 Intensity: 1.05 tCO2e/$MAptargroupYear: 2023Scope 1: 24,660 tCO2eRevenue: $M 3,487Scope 1 Intensity: 7.07 tCO2e/$MBio Rad LaboratoriesYear: 2022Scope 1: 21,216 tCO2eRevenue: $M 2,802Scope 1 Intensity: 7.57 tCO2e/$MAvantorYear: 2023Scope 1: 26,095 tCO2eRevenue: $M 6,967Scope 1 Intensity: 3.75 tCO2e/$MExact SciencesYear: 2024Scope 1: 12,121 tCO2eRevenue: $M 2,759Scope 1 Intensity: 4.39 tCO2e/$MBecton Dickinson and CoYear: 2023Scope 1: 162,475 tCO2eRevenue: $M 19,372Scope 1 Intensity: 8.39 tCO2e/$MCooper CompaniesYear: 2024Scope 1: 58,155 tCO2eRevenue: $M 3,895Scope 1 Intensity: 14.93 tCO2e/$MMettler-Toledo InternationalYear: 2024Scope 1: 27,797 tCO2eRevenue: $M 3,872Scope 1 Intensity: 7.18 tCO2e/$MBrukerYear: 2022Scope 1: 3,621 tCO2eRevenue: $M 2,531Scope 1 Intensity: 1.43 tCO2e/$MIlluminaYear: 2024Scope 1: 18,836 tCO2eRevenue: $M 4,372Scope 1 Intensity: 4.31 tCO2e/$MAgilent TechnologiesYear: 2024Scope 1: 29,698 tCO2eRevenue: $M 6,510Scope 1 Intensity: 4.56 tCO2e/$MWarby ParkerYear: 2023Scope 1: 961 tCO2eRevenue: $M 670Scope 1 Intensity: 1.43 tCO2e/$MBaxter InternationalYear: 2024Scope 1: 324,000 tCO2eRevenue: $M 10,636Scope 1 Intensity: 30.46 tCO2e/$MDENTSPLY SIRONAYear: 2024Scope 1: 4,705 tCO2eRevenue: $M 3,793Scope 1 Intensity: 1.24 tCO2e/$MTeleflexYear: 2024Scope 1: 16,256 tCO2eRevenue: $M 3,047Scope 1 Intensity: 5.33 tCO2e/$MMerit Medical SystemsYear: 2023Scope 1: 3,072 tCO2eRevenue: $M 1,257Scope 1 Intensity: 2.44 tCO2e/$MWatersYear: 2023Scope 1: 12,660 tCO2eRevenue: $M 2,956Scope 1 Intensity: 4.28 tCO2e/$MRepligenYear: 2023Scope 1: 2,236 tCO2eRevenue: $M 632Scope 1 Intensity: 3.54 tCO2e/$MIDEXX LaboratoriesYear: 2024Scope 1: 18,461 tCO2eRevenue: $M 3,898Scope 1 Intensity: 4.74 tCO2e/$MDexcomYear: 2023Scope 1: 5,383 tCO2eRevenue: $M 3,622Scope 1 Intensity: 1.49 tCO2e/$MEnvista HoldingsYear: 2024Scope 1: 3,000 tCO2eRevenue: $M 2,511Scope 1 Intensity: 1.19 tCO2e/$MIntuitive SurgicalYear: 2024Scope 1: 8,105 tCO2eRevenue: $M 8,352Scope 1 Intensity: 0.97 tCO2e/$MHologicYear: 2024Scope 1: 7,050 tCO2eRevenue: $M 4,030Scope 1 Intensity: 1.75 tCO2e/$MWest Pharmaceutical ServicesYear: 2024Scope 1: 31,327 tCO2eRevenue: $M 2,893Scope 1 Intensity: 10.83 tCO2e/$M

How does West Pharmaceutical Services's GHG emissions intensity compare to its peers?

In 2024, West Pharmaceutical Services reported a Scope 1 emissions intensity of 10.83 tCO₂e per millions USD. Compared to the peer group median of 4.28 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does West Pharmaceutical Services rank on GHG emissions intensity within its industry?

In 2024, West Pharmaceutical Services ranked 23 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places West Pharmaceutical Services among the least efficient performers, with one of the highest emissions intensities in its sector. a

Want Full Access to West Pharmaceutical Services's GHG Emissions Dataset?
Sign Up